Culture medium refinement by dialysis for the expansion of human induced pluripotent stem cells in suspension culture
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Human induced pluripotent stem cells (hiPSCs) secrete essential autocrine factors that are removed along with toxic metabolites when the growth medium is exchanged daily. In this study, after determining the minimum inhibitory level of lactic acid for hiPSCs, a medium refining system was constructed by which toxic metabolites were removed from used culture medium and autocrine factors as well as other growth factors were recycled. Specifically, about 87 % of the basic fibroblast growth factor and 80 % of transforming growth factor beta 1 were retained in the refined medium after dialysis. The refined medium efficiently potentiated the proliferation of hiPS cells in adherent culture. When the refining system was used to refresh medium in suspension culture, a final cell density of (1.1 ± 0.1) × 10 6 cells mL-1 was obtained, with 99.5 ± 0.2 % OCT 3/4 and 78.3 ± 1.1 % TRA-1-60 expression, on day 4 of culture. These levels of expression were similar to those observed in the conventional suspension culture. With this method, culture medium refinement by dialysis was established to remove toxic metabolites, recycle autocrine factors as well as other growth factors, and reduce the use of macromolecules for the expansion of hiPSCs in suspension culture.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since the discovery of iPSC generation, the field has transitioned from using PSC culture media containing animal reagents to Xeno-free and even animal-free media [64,65,66].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [64]
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Chemically defined conditions for human iPSC derivation and culture
Chen, G., Gulbranson, D. R., Hou, Z., Bolin, J. M., Ruotti, V., Probasco, M. D., Smuga-Otto, K., Howden, S. E., Diol, N. R., Propson, N. E., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1593 · Cited by 1,447 · cited 1×
“Although insulin, selenium, and L-ascorbic acid play prominent roles in cell survival, selfrenewal, and proliferation of hPSCs during multiple passages [36], the refined medium promoted the growth of hiPSCs without these components.”
BackgroundBadylak, S. F., Taylor, D., & Uygun, K. (2011) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071910-124743 · Cited by 1,041 · cited 1×
“Human induced pluripotent stem cells (hiPSCs) [1] hold great promise in the field of regenerative medicine for cellbased therapies [2, 3], tissue engineering [4], and drug discovery [5] because of their pluripotency and self-renewal capacity [6].”
BackgroundBasic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells
Xu, R.-H., Peck, R. M., Li, D. S., Feng, X., Ludwig, T., & Thomson, J. A. (2005) · Nature Methods · doi:10.1038/nmeth744 · Cited by 973
Stem cell therapy for human neurodegenerative disorders–how to make it work
Lindvall, O., Kokaia, Z., & Martinez-Serrano, A. (2004) · Nature Medicine · doi:10.1038/nm1064 · Cited by 915
James, D., Levine, A. J., Besser, D., & Hemmati-Brivanlou, A. (2005) · Development · doi:10.1242/dev.01706 · Cited by 896
Feeder-independent culture of human embryonic stem cells
Ludwig, T. E., Bergendahl, V., Levenstein, M. E., Yu, J., Probasco, M. D., & Thomson, J. A. (2006) · Nature Methods · doi:10.1038/nmeth902 · Cited by 681 · cited 4×
“The concentration of bFGF detected in the refined medium was lower than that in fresh medium (100 lg L) [24, 35], and most of the bFGF was found to be consumed by cells (Supplementary Fig.”
BackgroundInfluentialEnergy Metabolism in Human Pluripotent Stem Cells and Their Differentiated Counterparts
Varum, S., Rodrigues, A. S., Moura, M. B., Momcilovic, O., Easley, C. A., Ramalho-Santos, J., Van Houten, B., & Schatten, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020914 · Cited by 671
Feeder Layer- and Serum-Free Culture of Human Embryonic Stem Cells1
Amit, M., Shariki, C., Margulets, V., & Itskovitz-Eldor, J. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.103.021147 · Cited by 664
Bendall, S. C., Stewart, M. H., Menendez, P., George, D., Vijayaragavan, K., Werbowetski-Ogilvie, T., Ramos-Mejia, V., Rouleau, A., Yang, J., Bossé, M., et al. (2007) · Nature · doi:10.1038/nature06027 · Cited by 588 · cited 2×
“hESCs were previously reported to secrete bFGF and stimulate the production of TGF-b1 and insulin as autocrine factors in adherent culture [21, 22, 41, 42].”
BackgroundBasic Fibroblast Growth Factor Support of Human Embryonic Stem Cell Self-Renewal
Levenstein, M. E., Ludwig, T. E., Xu, R.-H., Llanas, R. A., VanDenHeuvel-Kramer, K., Manning, D., & Thomson, J. A. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0247 · Cited by 456 · cited 1×
“The concentration of bFGF detected in the refined medium was lower than that in fresh medium (100 lg L) [24, 35], and most of the bFGF was found to be consumed by cells (Supplementary Fig.”
BackgroundSchulz, T. C., Young, H. Y., Agulnick, A. D., Babin, M. J., Baetge, E. E., Bang, A. G., Bhoumik, A., Cepa, I., Cesario, R. M., Haakmeester, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037004 · Cited by 428 · cited 1×
“Human induced pluripotent stem cells (hiPSCs) [1] hold great promise in the field of regenerative medicine for cellbased therapies [2, 3], tissue engineering [4], and drug discovery [5] because of their pluripotency and self-renewal capacity [6].”
BackgroundXu, C., Rosler, E., Jiang, J., Lebkowski, J. S., Gold, J. D., O'Sullivan, C., Delavan‐Boorsma, K., Mok, M., Bronstein, A., & Carpenter, M. K. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0211 · Cited by 418
Effects of ammonia and lactate on hybridoma growth, metabolism, and antibody production
Ozturk, S. S., Riley, M. R., & Palsson, B. O. (1992) · Biotechnology and Bioengineering · doi:10.1002/bit.260390408 · Cited by 370 · cited 2×
“Human mesenchymal stem cells (hMSCs) and mouse hybridoma cells have been reported to tolerate more than 3 g L of lactic acid [29, 30], whereas human hematopoietic cells, Chinese hamster ovary (CHO) cells, and monkey kidney cells can tolerate about 2 g L of lactic acid [27, 28, 31, 32].”
BackgroundScalable expansion of human pluripotent stem cells in suspension culture
Zweigerdt, R., Olmer, R., Singh, H., Haverich, A., & Martin, U. (2011) · Nature Protocols · doi:10.1038/nprot.2011.318 · Cited by 271
Lao, M.-S., & Toth, D. (1997) · Biotechnology Progress · doi:10.1021/bp9602360 · Cited by 268 · cited 1×
“Human mesenchymal stem cells (hMSCs) and mouse hybridoma cells have been reported to tolerate more than 3 g L of lactic acid [29, 30], whereas human hematopoietic cells, Chinese hamster ovary (CHO) cells, and monkey kidney cells can tolerate about 2 g L of lactic acid [27, 28, 31, 32].”
BackgroundScalable Stirred-Suspension Bioreactor Culture of Human Pluripotent Stem Cells
Kehoe, D. E., Jing, D., Lock, L. T., & Tzanakakis, E. S. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0454 · Cited by 264
Growth inhibition in animal cell culture: The effect of lactate and ammonia
Hassell, T., Gleave, S., & Butler, M. (1991) · Applied Biochemistry and Biotechnology · doi:10.1007/bf02922022 · Cited by 259 · cited 1×
“Human mesenchymal stem cells (hMSCs) and mouse hybridoma cells have been reported to tolerate more than 3 g L of lactic acid [29, 30], whereas human hematopoietic cells, Chinese hamster ovary (CHO) cells, and monkey kidney cells can tolerate about 2 g L of lactic acid [27, 28, 31, 32].”
BackgroundGreber, B., Lehrach, H., & Adjaye, J. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0476 · Cited by 241
Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium
Furue, M. K., Na, J., Jackson, J. P., Okamoto, T., Jones, M., Baker, D., Hata, R.-I., Moore, H. D., Sato, J. D., & Andrews, P. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806136105 · Cited by 238 · cited 6×
“To determine the amounts of the remaining growth factors in the culture medium, the used medium was collected at t = 24 h and t = 96 h and analyzed by ELISA.”
MethodInfluentialDvorak, P., Dvorakova, D., Koskova, S., Vodinska, M., Najvirtova, M., Krekac, D., & Hampl, A. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0303 · Cited by 226 · cited 1×
“hESCs were previously reported to secrete bFGF and stimulate the production of TGF-b1 and insulin as autocrine factors in adherent culture [21, 22, 41, 42].”
BackgroundSuspension Culture of Human Pluripotent Stem Cells in Controlled, Stirred Bioreactors
Olmer, R., Lange, A., Selzer, S., Kasper, C., Haverich, A., Martin, U., & Zweigerdt, R. (2012) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2011.0717 · Cited by 202
Growth, Metabolism, and Growth Inhibitors of Mesenchymal Stem Cells
Schop, D., Janssen, F. W., van Rijn, L. D. S., Fernandes, H., Bloem, R. M., de Bruijn, J. D., & van Dijkhuizen-Radersma, R. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0345 · Cited by 184 · cited 1×
“Human mesenchymal stem cells (hMSCs) and mouse hybridoma cells have been reported to tolerate more than 3 g L of lactic acid [29, 30], whereas human hematopoietic cells, Chinese hamster ovary (CHO) cells, and monkey kidney cells can tolerate about 2 g L of lactic acid [27, 28, 31, 32].”
BackgroundOlmer, R., Haase, A., Merkert, S., Cui, W., Paleček, J., Ran, C., Kirschning, A., Scheper, T., Glage, S., Miller, K., et al. (2010) · Stem Cell Research · doi:10.1016/j.scr.2010.03.005 · Cited by 169
Embryonic stem cells in drug discovery
McNeish, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1281 · Cited by 165 · cited 1×
“Human induced pluripotent stem cells (hiPSCs) [1] hold great promise in the field of regenerative medicine for cellbased therapies [2, 3], tissue engineering [4], and drug discovery [5] because of their pluripotency and self-renewal capacity [6].”
BackgroundLuo, J., Vijayasankaran, N., Autsen, J., Santuray, R., Hudson, T., Amanullah, A., & Li, F. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.23291 · Cited by 154 · cited 2×
“Human mesenchymal stem cells (hMSCs) and mouse hybridoma cells have been reported to tolerate more than 3 g L of lactic acid [29, 30], whereas human hematopoietic cells, Chinese hamster ovary (CHO) cells, and monkey kidney cells can tolerate about 2 g L of lactic acid [27, 28, 31, 32].”
BackgroundSerra, M., Brito, C., Sousa, M. F. Q., Jensen, J., Tostões, R. M., Clemente, J. J., Strehl, R., Hyllner, J., Carrondo, M. J. T., & Alves, P. M. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.06.015 · Cited by 150
Chen, G., Gulbranson, D. R., Yu, P., Hou, Z., & Thomson, J. A. (2012) · Stem Cells · doi:10.1002/stem.1021 · Cited by 145
Abbasalizadeh, S., Larijani, M. R., Samadian, A., & Baharvand, H. (2012) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2012.0161 · Cited by 145 · cited 1×
“Moreover, suspension culture of hiPSCs in a bioreactor requires a large volume of culture medium, since spent medium is replaced daily with fresh medium to reduce the accumulation of lactic acid, ammonium (NH4 ), and other toxic metabolites, which increase with an increase in cell density [20].”
BackgroundAutomated maintenance of embryonic stem cell cultures
Terstegge, S., Laufenberg, I., Pochert, J., Schenk, S., Itskovitz‐Eldor, J., Endl, E., & Brüstle, O. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21061 · Cited by 120 · cited 2×
“08 (present study) g h 10 cells, respectively [17, 19], whereas it was 0.”
BackgroundStem/Progenitor Cell Sources of Insulin-Producing Cells for the Treatment of Diabetes
Lock, L. T., & Tzanakakis, E. S. (2007) · Tissue Engineering · doi:10.1089/ten.2007.0047 · Cited by 98
Tian, X., Morris, J. K., Linehan, J. L., & Kaufman, D. S. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.06.013 · Cited by 93 · cited 2×
“As suspension culture of hiPSC requires a large volume of medium supplemented with high concentration of growth factors (macromolecules) [23, 24], removal of autocrine factors during daily medium change results in high consumption of macromolecules.”
BackgroundChen, X., Chen, A., Woo, T. L., Choo, A. B. H., Reuveny, S., & Oh, S. K. W. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0077 · Cited by 89 · cited 4×
“types [15], and lactic acid has potential toxic effects on the proliferation of hPSC [16, 17].”
BackgroundInfluentialOuyang, A., Ng, R., & Yang, S.-T. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0322 · Cited by 87
Patel, S., Papoutsakis, E. T., Winter, J. N., & Miller, W. M. (2000) · Biotechnology Progress · doi:10.1021/bp000080a · Cited by 86 · cited 2×
“Human mesenchymal stem cells (hMSCs) and mouse hybridoma cells have been reported to tolerate more than 3 g L of lactic acid [29, 30], whereas human hematopoietic cells, Chinese hamster ovary (CHO) cells, and monkey kidney cells can tolerate about 2 g L of lactic acid [27, 28, 31, 32].”
BackgroundMontes, R., Ligero, G., Sánchez, L., Catalina, P., de la Cueva, T., Nieto, A., Melen, G. J., Rubio, R., García-Castro, J., Bueno, C., et al. (2009) · Cell Research · doi:10.1038/cr.2009.35 · Cited by 74 · cited 2×
“hESCs were previously reported to secrete bFGF and stimulate the production of TGF-b1 and insulin as autocrine factors in adherent culture [21, 22, 41, 42].”
BackgroundStem Cells for Heart Cell Therapies
Jing, D., Parikh, A., Canty, J. M., & Tzanakakis, E. S. (2008) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2008.0262 · Cited by 73
Haraguchi, Y., Matsuura, K., Shimizu, T., Yamato, M., & Okano, T. (2015) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1761 · Cited by 63
Influence of different ammonium, lactate and glutamine concentrations on CCO cell growth
Slivac, I., Blajić, V., Radošević, K., Kniewald, Z. M., & Srček, V. G. (2010) · Cytotechnology · doi:10.1007/s10616-010-9312-y · Cited by 49 · cited 1×
“This was important, because high concentrations of ammonium can be toxic to cells, causing cytosol vacuolization and subsequent cell death [34].”
BackgroundKinetics and metabolic specificities of Vero cells in bioreactor cultures with serum-free medium
Quesney, S., Marc, A., Gerdil, C., Giménez, C. L., Marvel, J., Richard, Y., & Meignier, B. (2003) · Cytotechnology · doi:10.1023/a:1026185615650 · Cited by 46 · cited 1×
“04 g h 10 cells for CHO, hybridoma, hematopoietic, and Vero cells, respectively [27, 28, 30, 33].”
BackgroundFernandes‐Platzgummer, A., Diogo, M. M., da Silva, C. L., & Cabral, J. M. S. (2013) · Biochemical Engineering Journal · doi:10.1016/j.bej.2013.11.014 · Cited by 22
Cited by
Sun, W., Starly, B., Daly, A. C., Burdick, J. A., Groll, J., Skeldon, G., Shu, W., Sakai, Y., Shinohara, M., Nishikawa, M., et al. (2020) · Biofabrication · doi:10.1088/1758-5090/ab5158 · Cited by 426
Allan, S. J., De Bank, P. A., & Ellis, M. J. (2019) · Frontiers in Sustainable Food Systems · doi:10.3389/fsufs.2019.00044 · Cited by 207
Impact of Culture Medium on Cellular Interactions in in vitro Co-culture Systems
Vis, M. A. M., Ito, K., & Hofmann, S. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00911 · Cited by 204
“Most previous studies focused on mass production, generally using large scale reactors (Chen et al., 2011; Nath et al., 2017).”
BackgroundMethodTowards resource-efficient and cost-efficient cultured meat
Hubalek, S., Post, M. J., & Moutsatsou, P. (2022) · Current Opinion in Food Science · doi:10.1016/j.cofs.2022.100885 · Cited by 161
Advances and Challenges in Cell Biology for Cultured Meat
Martins, B., Bister, A., Dohmen, R. G. J., Gouveia, M. A., Hueber, R., Melzener, L., Meßmer, T., Papadopoulos, J., Pimenta, J., Raina, D., et al. (2023) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-021022-055132 · Cited by 130
Metadata
- Authors
- Nath, S. C., Nagamori, E., Horie, M., & Kino-oka, M.
- Affiliations
- The University of Osaka (JP)
- Kyoto University (JP)
- Venue
- Bioprocess and Biosystems Engineering
- Published
- 2016-09-16
- Volume
- 40
- Issue
- 1
- Pages
- 123-131
- ISSN
- 1615-7591 (ISSN-L)
- 1615-7605
- OpenAlex
- W2519662005
- Cited by
- 53
- References
- 42
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 7 · 2023: 9 · 2022: 12 · 2021: 8 · 2020: 4 · 2019: 5 · 2017: 3
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Bioprocess and Biosystems Engineering (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science (15K06580)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- human induced pluripotent stem cells, dialysis, suspension culture, autocrine factors, toxic metabolites, lactic acid, basic fibroblast growth factor, TGF-β1, cell expansion, Oct4, TRA-1-60
- MeSH terms
- Culture Media, Dialysis, Humans, Cell Culture Techniques, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.